Transparency Market Research Medical Polymers, Resins and Fibers, Elastomers, Biodegradable Plastics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 2018 Single User License: US $ 4595 Buy Now Request Sample Published Date: Aug 2013 159 Pages Report Multi User License: US $ 7595 Corporate User License: US $ 10595 REPORT DESCRIPTION Global Medical Polymers Demand is Expected to Reach 6,411.7 kilo tons in 2018: Transparency Market Research Transparency Market Research published new market report "Medical Polymers, Resins and Fibers (PVC, PP, PE, PS), Elastomers (SBC, Rubber Latex), Biodegradable Plastics Market for Devices, Equipment, Packaging and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012-2018," the global medical polymers demand was 4,391.0 kilo tons in 2011 and is expected to reach 6,411.7 kilo tons in 2018, growing at a CAGR of 5.6% from 2012 to 2018. In terms of revenue, the market was valued at USD 8.4 billion in 2011 and is grow at a CAGR of 8.4% from 2012 to 2018. Increase in life expectancy leading to increased demand for healthcare treatment is expected to be the key driver for the medical polymers market. It is estimated that by 2050, over 16% of the global population would be over 65 years of age. This would result in
higher demand for home healthcare treatment as the above-mentioned populations is the key segment for the market. Home healthcare directly impacts the sale of medical disposables, which are increasingly being made from polymers owing to reduced cost and superior performance. The development and use of biodegradable plastic in medical industry is also expected to be a key feature responsible for the development of the market over the forecast period. Browse the full report at http://www.transparencymarketresearch.com/medicalpolymers-market.html Fibers and resins dominated the medical polymers market and accounted for over 85% of global consumption in 2011. PVC and PP were the highest consumed resins accounting for over 55% of the segment sale in 2011. However, engineering thermoplastics like PC and ABS are expected to have the fastest growth in the resins and fibers segment, growing at a CAGR of over 8% from 2012 to 2018. Medical Elastomers such as SBC, TPU, TPO, Silica Rubber and TPV among others were the second largest consumed product segment for the market and recorded consumption of over 550 kilo tons in 2011. In spite of its small market size, biodegradable plastics are expected to witness exponential growth over the forecast period. Medical polymers are used in applications such as medical devices and equipment, packaging, cardiology stents and tissue engineering. Medical devices and equipment was the most dominant application segment for medical polymers in 2011 accounting for nearly 50% of the global volume. Medical packaging was the second largest application segment in 2011 and is expected to witness the fastest growth over the forecast period owing to substitution of conventional materials such as glass by PVC, PP and engineering thermoplastics. North America was the largest consumer of medical polymers and consumed over 1,800 kilo tons in 2011. North America and Europe are expected to remain dominant markets for medical polymers over the next six years owing to the negligible impact of economic downturn on the medical industry in these regions. Asia Pacific is expected to be the fastest growing market over the forecast period majorly due to the shift in manufacturing activities from western countries to countries such as India and China. Some of the key participants profiled in the report include DuPont, BASF, Bayer Material Sciences, Eastman Chemicals, Dow Chemicals, Kraton and Evonik among others. The report gives a comprehensive view of the medical polymer market in terms of volume and revenue. In addition, the report includes current demand analysis and forecast for each product in North America, Europe, Asia Pacific and Rest of the World. The report comprises of the following segments: Medical Polymers Market: Product Segment Analysis Medical Resins and Fibers
Medical Elastomers Biodegradable Plastics The product segments have been further analyzed based on the materials used in various medical applications. Medical Resins and Fibers Polyvinyl chloride (PVC) Polypropylene (PP) Polyethylene (PE) Polystyrene (PS) Others (Engineering thermoplastics such as ABS, PC, PET) Medical Elastomers Styrene Block Copolymer (SBC) Rubber latex Others (TPU, TPV, TPO) Medical Polymers Market: Application Analysis Medical Devices and Equipment Medical Packaging Others (Tissue engineering, cardio stents) The report provides a cross-sectional analysis of all the above product segments with respect to the following regions: North America Europe Asia Pacific Rest of the World (RoW)
Browse the full report at http://www.transparencymarketresearch.com/medicalpolymers-market.html TABLE OF CONTENTS Chapter 1 Preface 1.1 Report description 1.2 Market segmentation 1.2.1 Global medical polymers market segmentation 1.3 Research methodology 1.4 Abbreviations Chapter 2 Executive Summary 2.1 Medical Polymers - Market Snapshot (2012 and 2018) Chapter 3 Global Medical Polymer: Industry Analysis 3.1 Introduction 3.2 Value chain analysis 3.3 Growth prospects for medical polymers 3.4 Market drivers 3.4.1 Growing demand for medical devices 3.4.2 Aging population leading to increased demand for medical treatment 3.4.3 Growing preference towards home healthcare treatment 3.5 Market restraints 3.5.1 Strict regulatory framework governing new product launches 3.5.2 Increasingly volatile raw material prices 3.6 Opportunities
3.6.1 Increasing importance of biodegradable materials in medical implants 3.7 Porter s five force analysis 3.7.1 Bargaining power of suppliers 3.7.2 Bargaining power of buyers 3.7.3 Threat of new entrants 3.7.4 Threat from substitutes 3.7.5 Degree of competition 3.8 Medical polymers: Market attractiveness analysis Chapter 4 Global Medical Polymers Market: Product Segment Analysis 4.1 Global medical polymers market, product segment overview, 2011 and 2018 4.2 Medical resins and fibers 4.2.1 Global medical resins and fibers market, product segment overview, 2011 and 2018 4.2.2 Polyvinyl chloride (PVC) 4.2.2.1 Global polyvinyl chloride (PVC) demand as medical polymer, 2011-2018 (Kilo Tons) (USD Million) 4.2.3 Polypropylene (PP) 4.2.3.1 Global polypropylene (PP) demand as medical polymer, 2011-2018 (Kilo Tons) (USD Million) 4.2.4 Polyethylene (PE) 4.2.4.1 Global polyethylene (PE) demand as medical polymer, 2011-2018 (Kilo Tons) (USD Million) 4.2.5 Polystyrene (PS) 4.2.5.1 Global Polypropylene (PS) demand as medical polymer, 2011-2018 (Kilo Tons) (USD Million) 4.2.6 Others
4.2.6.1 Global other thermoplastic materials demand as medical polymer, 2011-2018 (Kilo Tons) (USD Million) 4.3 Medical elastomers 4.3.1 Global medical elastomers market, product segment overview, 2011 and 2018 4.3.2 Styrene Block Coplymer 4.3.2.1 Global styrene block copolymer demand as medical polymer, 2011 2018 (Kilo Tons) (USD Million) 4.3.3 Rubber Latex 4.3.3.1 Global rubber latex demand as medical polymer, 2011 2018 (Kilo Tons) (USD Million) 4.3.4 Other Medical Elastomers 4.3.4.1 Global demand for other medical elastomers as medical polymers, 2011 2018 (Kilo Tons) (USD Million) 4.4 Biodegradable Plastics 4.4.1.1 Global biodegradable plastics demand as medical polymer, 2011 2018 (Kilo Tons) (USD Million) Chapter 5 Global Medical Polymers Market: Application Analysis 5.1 Global medical polymer market, application overview, 2011 and 2018 5.2 Medical polymer market, by application, 2011 2018 5.2.1 Global demand for medical polymer for use in medical devices and equipments, 2011 2018 (Kilo Tons) (USD Million) 5.2.2 Global demand for medical polymer for use in medical packaging, 2011 2018 (Kilo Tons) (USD Million) 5.2.3 Global demand for medical polymer in other application, 2011 2018 (Kilo Tons) (USD Million) Chapter 6 Global Medical Polymers Market: Regional Analysis 6.1 North America
6.1.1 North America medical polymer market volume, by product, 2011-2018 (kilo tons) 6.1.2 North America medical polymer market revenue, by product, 2011-2018 (USD Million) 6.1.3 North America medical fibers and resins market volume, by product, 2011-2018 (Kilo tons) 6.1.4 North America medical fibers and resins market revenue, by product, 2011-2018 (USD Million) 6.1.5 North America medical elastomers market volume, by product, 2011-2018 (kilo tons) 6.1.6 North America medical elastomers marketrevenue, by product, 2011-2018 (USD Million) 6.2 Europe 6.2.1 Europe medical polymer market, by product volume, 2011-2018 (kilo tons) 6.2.2 Europe medical polymer marketrevenue, by product, 2011-2018 (USD Million) 6.2.3 Europe medical fibers and resins market volume, by product, 2011-2018 (Kilo tons) 6.2.4 Europe medical fibers and resins marketrevenue, by product, 2011-2018 (USD Million) 6.2.5 Europe medical elastomers market volume, by product, 2011-2018 (kilo tons) 6.2.6 Europe medical elastomers market revenue, by product, 2011-2018 (USD Million) 6.3 Asia Pacific 6.3.1 Asia Pacific medical polymer market volume, by product, 2011-2018 (kilo tons) 6.3.2 Asia Pacific medical polymer market revenue, by product, 2011-2018 (USD Million) 6.3.3 Asia Pacific medical fibers and resins market volume, by product, 2011-2018 (Kilo tons) 6.3.4 Asia Pacific medical fibers and resins market revenue, by product, 2011-2018 (USD Million)
Browse the full report at http://www.transparencymarketresearch.com/medicalpolymers-market.html 6.3.5 Asia Pacific medical elastomers market volume, by product, 2011-2018 (kilo tons) 6.3.6 Asia Pacific medical elastomers marketrevenue, by product, 2011-2018 (USD Million) 6.4 Rest of the World (RoW) 6.4.1 Rest of the World medical polymer market volume, by product, 2011-2018 (Kilo Tons) 6.4.2 Rest of the World medical polymer market revenue, by product, 2011-2018 (USD Million) 6.4.3 Rest of the World medical fibers and resins market volume, by product, 2011-2018 (Kilo Tons) 6.4.4 Rest of the World medical fibers and resins market revenue, by product, 2011-2018 (USD Million) 6.4.5 Rest of the World medical elastomers market volume, by product, 2011-2018 (kilo tons) 6.4.6 Rest of the World medical elastomers marketrevenue, by product, 2011-2018 (USD Million) Chapter 7 Company Profiles 7.1 BASF SE 7.1.1 Company overview 7.1.2 Product portfolio 7.1.3 Financial overview 7.1.4 Business strategies 7.1.5 SWOT analysis 7.1.6 Recent developments 7.2 Bayer Material Science AG
7.2.1 Company overview 7.2.2 Product Portfolio 7.2.3 Financial overview 7.2.4 Business strategy 7.2.5 SWOT analysis 7.2.6 Recent developments 7.3 Celanese Corporation 7.3.1 Company overview 7.3.2 Product Portfolio 7.3.3 Financial overview 7.3.4 Business strategy 7.3.5 SWOT analysis 7.3.6 Recent developments 7.4 DSM N.V. 7.4.1 Company overview 7.4.2 Product Portfolio 7.4.3 Financial overview 7.4.4 Business strategy 7.4.5 SWOT analysis 7.4.6 Recent developments 7.5 E. I. du Pont de Nemours Company 7.5.1 Company overview 7.5.2 Product Portfolio 7.5.3 Financial overview 7.5.4 Business strategy
7.5.5 SWOT analysis 7.5.6 Recent developments 7.6 Eastman Chemical 7.6.1 Company overview 7.6.2 Product Portfolio 7.6.3 Financial overview 7.6.4 Business strategy 7.6.5 SWOT analysis 7.6.6 Recent developments 7.7 Evonik Industries AG 7.7.1 Company overview 7.7.2 Product Portfolio 7.7.3 Financial overview 7.7.4 Business strategy 7.7.5 SWOT analysis 7.7.6 Recent developments 7.8 Exxon Mobil Corporation 7.8.1 Company overview 7.8.2 Product Portfolio 7.8.3 Financial overview 7.8.4 Business strategy 7.8.5 SWOT analysis 7.8.6 Recent developments 7.9 The Dow Chemical Company 7.9.1 Company overview
7.9.2 Product Portfolio 7.9.3 Financial overview 7.9.4 Business strategy 7.9.5 SWOT analysis 7.9.6 Recent developments 7.10 Huizhou Foryou Medical Device Co. Ltd. 7.10.1 Company overview 7.10.2 Product portfolio 7.10.3 Business strategy 7.10.4 SWOT analysis 7.10.5 Recent developments 7.11 Kraton Performance Polymers Inc. 7.11.1 Company overview 7.11.2 Product portfolio 7.11.3 Financial Overview 7.11.4 Business strategy 7.11.5 SWOT analysis 7.11.6 Recent developments 7.12 Tianjin Plastics Research Institute Co. Ltd. 7.12.1 Company overview 7.12.2 Product portfolio 7.12.3 Business strategy 7.12.4 SWOT analysis 7.13 Formosa Plastics Corporation, U.S.A. 7.13.1 Company overview
7.13.2 Product Portfolio 7.13.3 Financial overview 7.13.4 Business strategy 7.13.5 SWOT analysis 7.13.6 Recent developments 7.14 Shanghai New Shanghua Polymer Material Co., Ltd. 7.14.1 Company overview 7.14.2 Product Portfolio 7.14.3 Business strategy 7.14.4 SWOT analysis 7.15 Sinopec Beijing Yanshan Company 7.15.1 Company overview 7.15.2 Financial overview 7.15.3 Business strategy 7.15.4 SWOT analysis 7.16 Ningbo Yonghua Resin Co. Ltd. 7.16.1 Company overview 7.16.2 Product portfolio 7.16.3 Business strategy 7.16.4 SWOT analysis 7.16.5 Recent developments 7.17 SINOPEC Shanghai Petrochemical Co. Ltd. 7.17.1 Company overview 7.17.2 Product portfolio 7.17.3 Financial overview
7.17.4 Business strategy 7.17.5 SWOT analysis 7.17.6 Recent developments 7.18 SABIC Innovative Plastics 7.18.1 Company overview 7.18.2 Product portfolio 7.18.3 Financial overview 7.18.4 Business strategy 7.18.5 SWOT analysis 7.18.6 Recent developments 7.19 Lubrizol Corporation 7.19.1 Company overview 7.19.2 Product Portfolio 7.19.3 Financial overview 7.19.4 Business strategy 7.19.5 SWOT analysis 7.19.6 Recent developments 7.20 Piaoan group 7.20.1 Company overview 7.20.2 Product Portfolio 7.20.3 Business strategy 7.20.4 SWOT analysis 7.20.5 Recent developments 7.21 Victrex Plc 7.21.1 Company overview
7.21.2 Product Portfolio 7.21.3 Financial overview 7.21.4 Business strategy 7.21.5 SWOT analysis 7.21.6 Recent developments 7.22 Huntsman Corporation 7.22.1 Company overview 7.22.2 Product Portfolio 7.22.3 Financial overview 7.22.4 Business strategy 7.22.5 SWOT analysis 7.22.6 Recent developments 7.23 China Haohua Chemical Group Co. 7.23.1 Company overview 7.23.2 Business strategy 7.23.3 SWOT analysis 7.23.4 Recent developments 7.24 INEOS 7.24.1 Company overview 7.24.2 Business strategy 7.24.3 SWOT analysis 7.24.4 Recent developments 7.25 Jafron Biomedical Co., Ltd. 7.25.1 Company overview 7.25.2 Product Portfolio
7.25.3 Business strategy 7.25.4 SWOT analysis 7.25.5 Recent developments 7.26 Solvay SA 7.26.1 Company overview 7.26.2 Product Portfolio 7.26.3 Financial overview 7.26.4 Business strategy 7.26.5 SWOT analysis 7.26.6 Recent developments 7.27 WEIGAO Holding Co. Ltd. (WEGO) 7.27.1 Company overview 7.27.2 Product Portfolio 7.27.3 Financial overview 7.27.4 Business strategy 7.27.5 SWOT analysis 7.27.6 Recent developments About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse the full report With TOC at http://www.transparencymarketresearch.com/medical-polymers-market.html